JANX
Janux Therapeutics Inc
16.70$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.2% | +0.2% | -4.9% | +0.8% | +0.4% | +1.4% | +4.2% | -7.4% | -6.6% | +0.2% | +98.7% | – | |
| – | -1.4% | +25.5% | +2.3% | +167.3% | -59.4% | +71.2% | +2.4% | -17.5% | +5.2% | -2.6% | +97.8% | – | |
| – | – | – | – | – | -102.7% | – | – | +74.3% | -146.7% | – | +566.5% | – | |
| – | +9.6% | -61.7% | -51.8% | -73.7% | +68.0% | +783.3% | +27.5% | -80.3% | +14.0% | +157.5% | +74.0% | – | |
| – | – | -1,122.5% | +67.8% | – | +167.7% | -1,103.3% | – | +431.8% | +255.7% | -72.0% | -468.1% | – | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | |
| – | -98.5% | +38,669.1% | -99.1% | -40.4% | +23,347.5% | -99.9% | +72.2% | -48.3% | +497.2% | +20.4% | +63.2% | – | |
| – | – | +9,330.0% | -202.3% | – | +3,239.8% | -188.4% | – | – | – | -112.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.